UCSF Specialties Among World’s Best in US News Global Universities Rankings for 2018
UCSF has ranked in the top 10 for seven specialties in 2017 Best Global Universities rankings released Tuesday by U.S. News & World Report.
University of California San Francisco
Give to UCSFUCSF has ranked in the top 10 for seven specialties in 2017 Best Global Universities rankings released Tuesday by U.S. News & World Report.
Scientists from Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and the University of California, San Francisco will hold a briefing to discuss Accelerating Therapeutics for Opportunities in Medicine
UCSF Health Informatics team has used electronic health records to track down a source of a common hospital-acquired infection.
UCSF researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they are all using the same mechanism to remodel normal tissue and spread.
The NCI has announced that UCSF will host one of five new Cancer Drug Resistance and Sensitivity Centers being set up around the U.S. through funding from the 21st Century Cures Act of 2016.
Researchers at UC San Francisco, the University of North Carolina-Chapel Hill, and Stanford University report a major step toward designing more powerful psychiatric drugs with fewer side effects.
In the first study looking at cessation of alcohol consumption and atrial fibrillation risk, UCSF researchers have shown that the longer people abstain from drinking alcohol, the lower their risk of AF.
Encellin obtained exclusive rights from UCSF for a proprietary cell encapsulation technology aimed at improving physicians’ ability to perform cell transplants without the need for immunosuppressive drugs.
An FDA warning against a tool used to break up fibroid tissue during laparoscopic surgeries has led to a shift toward more invasive surgeries for hysterectomies for women with uterine fibroids.
A new UC San Francisco–led study shows that failure to follow this basic principle of population science can profoundly skew the results of brain imaging studies.
UCSF scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic MS.
Study shows, over the course of 19 years, the hard core group smoked progressively fewer cigarettes per day and tried to quit in increasingly greater numbers, along with every other group of smokers in the US.
UCSF researcher Saul Kato is using a new high-resolution whole-brain imaging technique to see how the entire nervous system of a worm works together to generate behavior.
U.S. hospitals are making slow progress in ensuring that their providers have access to and use patients’ complete electronic health records when those patients have also received care from outside providers.